Gaudium IVF & Women Health Limited has launched its ₹165 crore IPO, opening for subscription on February 20, 2026. With a price band of ₹75–79 per share and a moderate grey market premium, analysts remain cautiously optimistic. Funds will be used for expansion of IVF centers and debt repayment.
Gaudium IVF, a leading fertility and women’s healthcare provider, has entered the capital markets with its Initial Public Offering (IPO). The issue size is ₹165 crore, aimed at financing new IVF centers across India and reducing debt. Brokerages highlight the company’s strong presence in the growing fertility services sector, supported by rising demand due to lifestyle changes and delayed parenthood.
Key Highlights
-
IPO Size: ₹165 crore mainboard issue.
-
Price Band: ₹75–79 per share; lot size of 189 shares.
-
Subscription Window: Opens February 20, 2026; closes February 24, 2026.
-
Grey Market Premium (GMP): Hovering around ₹10, indicating moderate listing expectations.
-
Use of Proceeds: Expansion of IVF centers and debt repayment.
-
Sector Outlook: Fertility services are witnessing strong growth, driven by rising infertility rates and increasing awareness.
-
Brokerage View: Analysts recommend subscription, citing improving financial performance and long-term growth potential.
Sources: Economic Times, IPO Watch, IPO Review 2026